Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600423 Liuzhou Chemical Industry
- 3.39
- +0.09+2.73%
Market Closed Dec 12 15:00 CST
2.71BMarket Cap28.97P/E (TTM)
3.40High3.29Low145.06KlotVolume3.30Open3.30Pre Close48.56MTurnover1.82%Turnover Ratio36.85P/E (Static)798.70MShares4.1152wk High4.90P/B2.71BFloat Cap1.9752wk Low3.63Limit Up798.70MShs Float16.19Historical High2.97Limit Down3.33%Amplitude1.97Historical Low--Dividend TTM3.35Avg Price63.36KlotAsk--Div YieldTTM100Lot Size79.80KlotBid
Liuzhou Chemical Industry Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 39.29%129.52M | 37.70%77.48M | 10.21%32.44M | 1.03%141.9M | -11.88%92.99M | -14.95%56.27M | -11.31%29.44M | 10.35%140.46M | 16.80%105.53M | 10.54%66.16M |
| Operating revenue | 39.29%129.52M | 37.70%77.48M | 10.21%32.44M | 1.03%141.9M | -11.88%92.99M | -14.95%56.27M | -11.31%29.44M | 10.35%140.46M | 16.80%105.53M | 10.54%66.16M |
| Other operating revenue | ---- | -43.82%105.39K | ---- | 62.28%1.06M | ---- | -33.84%187.58K | ---- | -86.09%653.46K | ---- | -86.93%283.52K |
| Total operating cost | 20.76%98.73M | 14.79%61.95M | 9.07%29.9M | 2.29%113.9M | -3.37%81.76M | -2.83%53.97M | -8.18%27.42M | 9.94%111.35M | 28.56%84.62M | 41.25%55.54M |
| Operating cost | 16.02%98.6M | 11.11%61.89M | 4.53%30.1M | -1.31%114.46M | -3.97%84.98M | -4.12%55.7M | -7.08%28.8M | 14.16%115.98M | 28.24%88.49M | 43.21%58.09M |
| Operating tax surcharges | 245.32%554.05K | 100.03%274.59K | 28.91%62.09K | -43.99%362.37K | -63.73%160.44K | -46.43%137.28K | -31.39%48.16K | -17.58%646.97K | -15.76%442.35K | -41.47%256.25K |
| Operating expense | 49.49%666.32K | 64.08%450.31K | 20.17%175.45K | 32.25%700.36K | 27.28%445.72K | 20.72%274.45K | 18.95%146K | 39.39%529.58K | 42.77%350.19K | 37.67%227.34K |
| Administration expense | 17.44%7.61M | 7.71%5.07M | 13.95%2.14M | 7.49%8.91M | 8.34%6.48M | 16.10%4.7M | -16.26%1.88M | -30.78%8.29M | -0.43%5.98M | -14.66%4.05M |
| Financial expense | -1.40%-10.45M | -4.81%-7.18M | -0.12%-3.45M | 2.47%-13.75M | 3.24%-10.31M | 3.38%-6.85M | 3.26%-3.45M | -4.75%-14.09M | -6.87%-10.65M | -7.46%-7.09M |
| -Interest expense (Financial expense) | --75K | --21.3K | --10.73K | --42.15K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | -2.16%-10.53M | -5.17%-7.2M | -0.42%-3.47M | 2.13%-13.79M | 3.25%-10.31M | 3.38%-6.85M | 3.29%-3.45M | -4.61%-14.09M | -6.74%-10.65M | -7.30%-7.09M |
| Research and development | --1.75M | --1.45M | --879.95K | --3.21M | ---- | ---- | ---- | ---- | ---- | ---- |
| Credit Impairment Loss | -348.18%-308.81K | -348.18%-308.81K | ---- | 51.43%-34.81K | -126.74%-68.9K | -126.74%-68.9K | ---- | -128.05%-71.68K | -111.51%-30.39K | -111.51%-30.39K |
| Other net revenue | 553.90%300.79K | 301.76%133.7K | -8.23%2.42K | 153.30%188.41K | -141.43%-66.27K | -141.43%-66.27K | -8.46%2.64K | -115.34%-353.49K | -109.97%-27.45K | -109.97%-27.45K |
| Asset deal income | --17.09K | ---- | ---- | ---- | ---- | ---- | ---- | -113.97%-284.75K | ---- | ---- |
| Other revenue | 22,371.54%592.52K | 16,682.72%442.52K | -8.23%2.42K | 7,489.86%223.23K | -10.35%2.64K | -10.35%2.64K | -8.46%2.64K | -74.28%2.94K | -74.28%2.94K | -74.28%2.94K |
| Operating profit | 178.66%31.09M | 601.64%15.66M | 25.72%2.54M | -1.97%28.19M | -46.57%11.16M | -78.93%2.23M | -39.39%2.02M | 1.57%28.76M | -15.83%20.88M | -49.09%10.59M |
| Add:Non operating Income | --0.24 | --0.24 | --0.24 | 66,012.98%45.08M | ---- | ---- | ---- | -86.78%68.18K | -93.48%33.08K | -94.04%29.98K |
| Less:Non operating expense | --200 | ---- | ---- | -99.85%20K | ---- | ---- | ---- | 93,634.36%12.97M | 112,871.58%13.25M | ---- |
| Total profit | 178.66%31.09M | 601.64%15.66M | 25.72%2.54M | 361.94%73.25M | 45.64%11.16M | -78.98%2.23M | -39.39%2.02M | -44.97%15.86M | -69.73%7.66M | -50.14%10.62M |
| Less:Income tax cost | --35.75K | --9.66K | --1.96K | ---4.27K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | 178.34%31.05M | 601.21%15.65M | 25.63%2.54M | 361.97%73.25M | 45.64%11.16M | -78.98%2.23M | -39.39%2.02M | -44.97%15.86M | -69.73%7.66M | -50.14%10.62M |
| Net profit from continuing operation | 178.34%31.05M | 601.21%15.65M | 25.63%2.54M | 361.97%73.25M | 45.64%11.16M | -78.98%2.23M | -39.39%2.02M | -44.97%15.86M | --7.66M | --10.62M |
| Net profit of parent company owners | 178.34%31.05M | 601.21%15.65M | 25.63%2.54M | 361.97%73.25M | 45.64%11.16M | -78.98%2.23M | -39.39%2.02M | -44.97%15.86M | -69.73%7.66M | -50.14%10.62M |
| Earning per share | ||||||||||
| Basic earning per share | 178.57%0.039 | 566.67%0.02 | 0.00%0.003 | 350.00%0.09 | 40.00%0.014 | -76.92%0.003 | -25.00%0.003 | -50.00%0.02 | -68.75%0.01 | -51.85%0.013 |
| Diluted earning per share | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -51.85%0.013 |
| Other composite income | ||||||||||
| Total composite income | 178.34%31.05M | 601.21%15.65M | 25.63%2.54M | 361.97%73.25M | 45.64%11.16M | -78.98%2.23M | -39.39%2.02M | -44.97%15.86M | -69.73%7.66M | -50.14%10.62M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
